Correlation of cytokines and mobility in mice with arthritis and during therapy with Swertia chirayita

Journal of Herbal Pharmacotherapy

Volumn 4, Issue 2, 2004, Pages 33-45

  Kumar, Pradeep ^a   Paul, Bholanath ^a,b   Kumar, Sirish ^a   Ali, Mohammad ^a   Sexana, Ashok K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b Indust Toxicology Research Centre ^*

Author keywords

Arthritis; Cytokines; Inflammation; Mobility; Swertia chirayita

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; SWERTIA CHIRAYITA EXTRACT; SWERTIA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; INTERLEUKIN 1; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANCE PERCEPTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HINDLIMB; JOINT FUNCTION; JOINT MOBILITY; MOUSE; MOUSE STRAIN; NONHUMAN; PLANT STEM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWERTIA; SWERTIA CHIRAYITA; ANIMAL; CHEMISTRY; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MOTOR ACTIVITY; PHYTOTHERAPY; SYNOVIUM;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CYTOKINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; MICE; MOTOR ACTIVITY; PHYTOTHERAPY; PLANT EXTRACTS; SWERTIA; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8744281451     PISSN: 15228940     EISSN: None     Source Type: Journal    
DOI: 10.1300/J157v04n02_04     Document Type: Article

References (22)

1. Lee DM, Friend DS, Gurish MF, Benoist C, Mathis D, Brenner, MB. Mast cells: A cellular link between autoantibodies and inflammatory arthritis. Science 2002; 297: 1689-92.
2. Horstman J. The Arthritis Foundations Guide to Alternative Therapies. Atlanta: Arthritis Foundation, 1999.
3. Paul BN, Saxena AK. Depletion of TNF-α in mice by Nyctanthes arbortristis. J Ethnopharmacol. 1997; 56: 153-8.
4. Choy E, Panayi GS. Cytokine pathways and joint inflammation in rheumatoid arthritis. New Eng J Med. 2001; 344: 907-16.
5. Szekanecz Z, Halloran MN, Volin MV, Woods JM, Strieter RM, Haevies GK, et al. Temporal expression of inflammatory cytokines and chemokines in rat adjuvant induced arthritis. Arthritis Rheumat. 2000; 43: 1266-77.
6. Mussener A, Litton MJ, Lindroos E, Klareskog L. Cytokine production in synovial tissue of mice with CIA. Clin Exp Immunol. 1997; 107: 485-93.
7. Plamblad K, Harris HE, Tracey KJ, Andersson U. Dynamics of early synovial cytokine expression in rodent collagen-induced arthritis. Am J Pathol. 2001; 158: 491-500.
8. Francischi JN, Yokoro CM, Poole S, Tafuri WL, Cunha FQ, Teixera MM. Anti-inflammatory and analgesic effects of the phosphodiesterase inhibitor roliparm in a rat model of arthritis. Eur J Pharmacol. 2000; 399: 243-49.
9. Kefler J, Probert L, Cazlaris H, Geogopoulos S, Kaslaris E, Kioussis D, Kollias G. Transgenic mice expressing human tumor necrosis factor: A predictive genetic model of arthritis. EMBO J 1991; 10: 4025-31.
10. Saijo S, Asano M, Horai R, Yamanoto H, Jwakura Y. Suppression of autoimmune arthritis in interleukine-1 deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX 40 expression on T cells. Arthritis Rheumat. 2002; 46: 533-44.
11. Boe A, Baiocchi M, Carbonatto M, Papoian R, Serlupi-Crescanzi O. Interleukin-6 knock out mice are resistant to antigen-induced experimental arthritis. Cytokine. 1999; 11: 1057-64.
12. Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K, Nomura S, Kopf M, Katada Y, Tanaka T, Suemura M, Kishimoto T. Interleukin-6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci. 1998; 95: 8222-6.
13. Shankaranarayan D, Gopalkrishnan C, Kameswaran L. Pharmacology of mangiferin. Ind J Pharmaceut Sci. 1979; 41: 78-9.
14. Shankaranarayan D, Gopalkrishnan C, Kameswaran L. Pharmacological profile of Mangiferin and its derivatives. Arch Therap Pharmacodyn. 1979; 239: 257-69.
15. Mandal S, Das PC, Joshi PC, Chatterjee A, Islam CN, Datta MK, Patra BB, Sikdar S. Anti-inflammatory action of Swertia chirayita. Fitoterapia 1992; 63: 122-8.
16. Banerjee S, Sur TK, Mandal S, Das PC, Sikdar S. Assessment of the anti-inflammatory effect of Swertia chirayita in acute and chronic experimental models in male albino rats. Ind J Pharmacol. 2000; 32: 21-4.
17. Bliven ML, Eskra JD, Otterness IG. Limitation of activity in an acute model of arthritis: Effect of drug treatment. Inflam Res. 1997; 46: 491-5.
18. Otterness IG, Bliven ML, Milici AJ, Poole AR. Comparison of mobility changes with histologic and biochemical changes during LPS induced arthritis in the hamster. Am J Pathol. 1994a; 144: 1098-108.
19. Graeme ML, Fabry E, Sigg B. Mycobacterium adjuvant periarthiritis in rodents and its modification by anti-inflammatory agents. J Pharmacol Exp Therap. 1966; 153: 373-80.
20. Otterness IG, Milici AJ, Bliven ML. Some factors affecting inhibition and restoration of mobility after induction of an acute arthritis in the hamster. Agents Action 1994b; 40: 224-7.
21. Otterness IG, Sipe J, Sinohara S, Carreras I, Yamamoto K, Bliven ML. Serum Amyloid A is a sensitive marker of reduced activity in arthritic hamsters. Int J Clin Investig. 1994c; 1: 165-73.
22. Chang RW, Dunlop D, Gibbs J, Hughes S. The determinants of walking velocity in the elderly. An evaluation using regression trees. Arthritis Rheumat. 1995; 38: 343-50.